Step 1 topics → Microbiology → Influenza

Influenza

USMLE Step 1 trap: Confuses which antigenic change mechanism drives pandemics vs. seasonal epidemics. Antigenic shift (reassortment of gene segments between strains) causes pandemics; drift causes seasonal epidemics via gradual point mutations.

Influenza is a segmented, negative-sense, single-stranded RNA virus that USMLE Step 1 tests from multiple angles, and the antigenic drift vs. shift distinction is the most reliably inverted. Drift is gradual point mutations in HA/NA — it drives seasonal epidemics and partial immunity. Shift is wholesale gene segment reassortment between two influenza A strains co-infecting the same cell — it produces an entirely new HA/NA combination with zero population immunity, which is why only shift causes pandemics. Critically, only influenza A undergoes reassortment because only A infects multiple species (humans, birds, pigs); influenza B infects only humans and has no animal reservoir to introduce foreign segments.

The exam tests influenza in ways that go beyond simple recall. You'll get vignettes asking you to distinguish why one outbreak became a pandemic while another stayed seasonal, or asking what killed a patient who seemed to be recovering from the flu. The passage might give you clues about the pathogen (e.g., 'cavitary lesion on CXR 10 days after flu-like illness') and expect you to name the complication, not the primary virus. These application questions are where most students lose points.

The trickiest part of influenza on USMLE Step 1 is the cluster of related misconceptions around antigenic drift vs. shift. Students frequently invert which one causes pandemics, or they incorrectly apply reassortment to influenza B. Similarly, oseltamivir's mechanism gets confused with amantadine's or with viral entry blockers — the exam will absolutely probe this distinction. And the live attenuated vaccine (LAIV) contraindications are a classic management trap that appears more often than students expect.

From real student decks
84%have cards covering this topic
68%have mature cards

Common misconceptions

Common mistake
Wrong: Antigenic drift causes pandemics because it produces the most dramatic changes.
Right: Antigenic shift (reassortment of gene segments between strains) causes pandemics; drift causes seasonal epidemics via gradual point mutations.
Antigenic drift involves slow, accumulating point mutations in hemagglutinin (HA) or neuraminidase (NA) — enough change to evade prior immunity, but not enough to be completely novel. This is why you need a new flu shot each year, but existing immunity still provides partial protection, so outbreaks stay regional and seasonal. Antigenic shift is a completely different event: two influenza A strains co-infect the same cell, their segmented genomes mix, and an entirely new HA/NA combination emerges. Because no one has seen this combination before, there's zero population immunity — that's what fuels a pandemic.
Common mistake
Wrong: Antigenic shift can occur in influenza A, B, and C viruses equally.
Right: Antigenic shift occurs only in influenza A because only influenza A infects multiple species (humans, birds, pigs), enabling reassortment.
Reassortment requires two strains to infect the same cell simultaneously, which demands a virus that has a broad enough host range to circulate in multiple species at once. Influenza A infects humans, birds, and pigs — meaning a human strain and an avian strain can meet inside a pig (the classic 'mixing vessel') and swap gene segments. Influenza B infects only humans, so there's no animal reservoir to introduce a foreign genome. Influenza C is similarly restricted. Only influenza A has pandemic potential through reassortment.
Common mistake
Wrong: Viral pneumonia from influenza itself is the most common cause of post-influenza death.
Right: Secondary bacterial pneumonia (most commonly S. aureus, S. pneumoniae, H. influenzae) is the leading cause of post-influenza mortality.
The flu damages ciliated respiratory epithelium, impairs mucociliary clearance, and suppresses local immune defenses — this creates a perfect window for bacterial colonization. The classic pattern is a patient who improves after several days of flu symptoms, then rapidly deteriorates with new fever, productive cough, and lobar consolidation. S. aureus (including MRSA) is particularly dangerous because it produces toxins that worsen the already-damaged epithelium. Direct viral pneumonia exists but is much less common and typically seen in very high-risk patients; bacterial superinfection drives the mortality statistics.
Common mistake
Wrong: Oseltamivir blocks viral entry into host cells.
Right: Oseltamivir inhibits neuraminidase, preventing release of newly formed virions from infected cells.
Oseltamivir (Tamiflu) and zanamivir are neuraminidase inhibitors — they work at the end of the viral replication cycle, not the beginning. Neuraminidase cleaves sialic acid residues that tether newly assembled virions to the infected cell surface. Block neuraminidase, and the virions stay clumped at the cell surface instead of spreading to infect new cells. This is fundamentally different from amantadine/rimantadine, which block the M2 ion channel and interfere with viral uncoating (an early entry step) — and it's also different from any fusion or receptor-binding inhibitor.
Common mistake
Wrong: The live attenuated intranasal influenza vaccine (LAIV) can be given to immunocompromised patients and pregnant women.
Right: LAIV is contraindicated in immunocompromised individuals, pregnant women, and children under 2; inactivated vaccine is used instead.
LAIV contains live, replicating (though attenuated) virus — which means it requires an intact immune system to stay controlled. In immunocompromised patients, the attenuated virus can cause actual disease. In pregnant women, any live vaccine carries a theoretical risk to the fetus. In children under 2, the immune system is immature and the risk of febrile reactions is higher. The inactivated intramuscular vaccine has none of these concerns and is the correct choice for all of these groups. LAIV is appropriate only for healthy, non-pregnant individuals aged 2–49.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a description of an outbreak — seasonal vs. pandemic scale — identify whether antigenic drift (gradual point mutations in HA/NA) or antigenic shift (reassortment of gene segments, influenza A only) is responsible, and explain why one causes limited epidemics while the other causes global pandemics.
  2. Recognize post-influenza complications in clinical vignettes: secondary bacterial pneumonia (S. aureus, S. pneumoniae, H. influenzae) is the leading cause of post-influenza death — not direct viral pneumonia — and a patient who 'was getting better then got worse' should trigger this diagnosis.
  3. Match the correct antiviral or vaccine to the correct population: oseltamivir/zanamivir (neuraminidase inhibitors) for treatment, LAIV contraindicated in immunocompromised patients/pregnant women/children under 2, and inactivated vaccine as the safe default for high-risk groups.

Can you avoid these mistakes?

A novel influenza strain emerges containing hemagglutinin from an avian strain and neuraminidase from a human strain. What mechanism produced this virus, and why can this only happen with influenza A and not influenza B?
A 55-year-old man is recovering from confirmed influenza when, on day 8, he develops worsening fever, pleuritic chest pain, and a new infiltrate with early cavitation on CXR. What is the most likely cause of his deterioration, and what are the top three responsible pathogens?
A patient asks for the nasal spray flu vaccine (LAIV) instead of the shot. She is 34 years old, currently pregnant, and on low-dose prednisone for rheumatoid arthritis. Is LAIV appropriate? What about after delivery if she is breastfeeding?
Oseltamivir is started within 48 hours of influenza symptom onset. At what specific step in the viral life cycle does it act, and how does this differ mechanistically from amantadine?

Related topics

Bacterial Staining and Structure Bacterial Culture Requirements Encapsulated Organisms Bacterial Exotoxins

See how your Anki deck covers this topic.

Upload your deck for a free audit →